Suppr超能文献

单一学术机构2004 - 2013年食管疾病治疗的进展

Evolution in the Treatment of Esophageal Disease at a Single Academic Institution: 2004-2013.

作者信息

Dolan James P, McLaren Patrick J, Diggs Brian S, Schipper Paul H, Tieu Brandon H, Sheppard Brett C, Gilbert Erin W, Conroy Molly A, Hunter John G

机构信息

1 Division of Gastrointestinal & General Surgery, Department of Surgery, the Knight Cancer Institute, Oregon Health & Science University , Portland, Oregon.

2 Division of Cardiothoracic Surgery, Section of General Thoracic Surgery, Department of Surgery, Oregon Health & Science University , Portland, Oregon.

出版信息

J Laparoendosc Adv Surg Tech A. 2017 Sep;27(9):915-923. doi: 10.1089/lap.2017.0069. Epub 2017 May 9.

Abstract

INTRODUCTION

Management of benign and malignant esophageal disease has changed rapidly over the past decade. The aim of this study was to analyze evolution in surgical management of esophageal disease at a single academic medical center during this period.

MATERIALS AND METHODS

We reviewed a retrospective cohort of patients who underwent esophagectomy between 2004 and 2013. Patient, institutional, treatment, and outcomes variables were reviewed.

RESULTS

317 patients were analyzed. Median age was 63.5 years; 80% were male. Average inhospital mortality rate was 3.8%. Operative indications changed significantly from 2004 to 2013, with more operations performed for invasive malignancy (77% vs. 95%) and fewer for high-grade dysplasia (12% vs. 3%, P = .008). In 2004, Ivor Lewis esophagectomy was the most common surgical technique, but the three-field technique was the operation of choice in 2013. A minimally invasive approach was used in 19% of cases in 2004 and 100% of cases in 2013 (P < .001). Anastomotic leak ranged from 0% to 21% with no significant difference over the study period (P = .18). Median lymph node harvest increased from seven to 18 nodes from 2004 to 2013 (P = .001). Hospital length of stay decreased from 15 to 8 days (P = .001). In 2013, 79% of patients were discharged to home, compared to 73% in 2004 (P = .04).

DISCUSSION

Over the last decade, our treatment of esophageal disease has evolved from a predominantly open Ivor Lewis to a minimally invasive three-field approach. Operations for malignancy have also increased dramatically. Postoperative complications and mortality were not significantly changed, but were consistently low during the latter years of the study.

摘要

引言

在过去十年中,良性和恶性食管疾病的治疗方法发生了迅速变化。本研究的目的是分析在此期间一家学术医疗中心食管疾病手术治疗的演变情况。

材料与方法

我们回顾了2004年至2013年间接受食管切除术的患者的回顾性队列。对患者、机构、治疗和结果变量进行了审查。

结果

分析了317例患者。中位年龄为63.5岁;80%为男性。平均住院死亡率为3.8%。从2004年到2013年,手术适应症发生了显著变化,侵袭性恶性肿瘤的手术例数增加(77%对95%),高级别发育异常的手术例数减少(12%对3%,P = 0.008)。2004年,艾弗·刘易斯食管切除术是最常见的手术技术,但2013年三野手术是首选术式。2004年19%的病例采用了微创方法,2013年为100%(P < 0.001)。吻合口漏率在0%至21%之间,在研究期间无显著差异(P = 0.18)。从2004年到2013年,中位淋巴结清扫数从7个增加到18个(P = 0.001)。住院时间从15天减少到8天(P = 0.001)。2013年,79%的患者出院回家,2004年为73%(P = 0.04)。

讨论

在过去十年中,我们对食管疾病的治疗已从主要的开放性艾弗·刘易斯手术演变为微创三野手术。恶性肿瘤的手术例数也大幅增加。术后并发症和死亡率没有显著变化,但在研究后期一直较低。

相似文献

1
Evolution in the Treatment of Esophageal Disease at a Single Academic Institution: 2004-2013.
J Laparoendosc Adv Surg Tech A. 2017 Sep;27(9):915-923. doi: 10.1089/lap.2017.0069. Epub 2017 May 9.
2
Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
Ann Thorac Surg. 2016 Mar;101(3):1097-103. doi: 10.1016/j.athoracsur.2015.09.062. Epub 2015 Dec 1.
4
Evolving changes of minimally invasive esophagectomy: a single-institution experience.
Surg Endosc. 2020 Jun;34(6):2503-2511. doi: 10.1007/s00464-019-07057-6. Epub 2019 Aug 5.
6
Minimally Invasive Ivor Lewis Esophagectomy (MILE): technique and outcomes of 100 consecutive cases.
Surg Endosc. 2020 Jul;34(7):3243-3255. doi: 10.1007/s00464-020-07529-0. Epub 2020 Apr 6.
7
Incidence and impact of postoperative atrial fibrillation after minimally invasive esophagectomy.
Dis Esophagus. 2016 Aug;29(6):583-8. doi: 10.1111/dote.12355. Epub 2015 Mar 30.

引用本文的文献

3
Post-esophagectomy hiatal hernia following minimally invasive esophagectomy in esophageal cancer patients.
Surg Endosc. 2025 Apr;39(4):2588-2596. doi: 10.1007/s00464-025-11639-y. Epub 2025 Mar 5.

本文引用的文献

1
Minimally Invasive Esophagectomy: A New Era of Surgical Resection.
J Laparoendosc Adv Surg Tech A. 2016 Apr;26(4):276-80. doi: 10.1089/lap.2016.0088. Epub 2016 Apr 5.
2
The Global Burden of Esophageal Cancer: A Disability-Adjusted Life-Year Approach.
World J Surg. 2016 Feb;40(2):395-401. doi: 10.1007/s00268-015-3356-2.
3
Extent of Lymphadenectomy and Prognosis After Esophageal Cancer Surgery.
JAMA Surg. 2016 Jan;151(1):32-9. doi: 10.1001/jamasurg.2015.2611.
4
Endoscopic mucosal resection for staging and treatment of early esophageal carcinoma: a single institution experience.
Surg Endosc. 2015 Aug;29(8):2121-5. doi: 10.1007/s00464-014-3962-3. Epub 2014 Dec 4.
5
Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer.
J Natl Cancer Inst. 2014 Jul 16;106(7). doi: 10.1093/jnci/dju133. Print 2014 Jul.
7
Overall survival analysis of neoadjuvant chemoradiotherapy and esophagectomy for esophageal cancer.
J Gastrointest Oncol. 2014 Apr;5(2):86-91. doi: 10.3978/j.issn.2078-6891.2014.014.
8
Personalizing therapy for esophageal cancer patients.
Thorac Surg Clin. 2013 Nov;23(4):471-8. doi: 10.1016/j.thorsurg.2013.07.001.
9
Outcomes following laparoscopic transhiatal esophagectomy for esophageal cancer.
Surg Endosc. 2014 Feb;28(2):492-9. doi: 10.1007/s00464-013-3230-y. Epub 2013 Oct 8.
10
The short-term outcome of three-field minimally invasive esophagectomy for Siewert type I esophagogastric junctional adenocarcinoma.
Ann Thorac Surg. 2013 Nov;96(5):1826-31. doi: 10.1016/j.athoracsur.2013.06.058. Epub 2013 Aug 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验